Nav: Home

ASCO honors M. D. Anderson Cancer Prevention head

June 04, 2004

NEW ORLEANS - The vice president for cancer prevention at The University of Texas M. D. Anderson Cancer Center has been honored with the 2004 American Cancer Society Award from the American Society of Clinical Oncology (ASCO).

Bernard Levin, M.D., is the 12th recipient of the honor that began in 1993 to recognize leaders in oncology who have made significant contributions throughout their careers to preventing and managing cancer.

Levin, a colorectal cancer expert, will receive the award at ASCO's annual meeting, where he will deliver an acceptance lecture titled, "Prevention of Colorectal Neoplasia: Biology, Targeted Interventions, Politics and Hope" on June 6.

For nearly three decades, Levin has furthered the science and application of cancer prevention through developing and implementing multidisciplinary programs in research, service and education, beginning when there was little scientific data or support for the notion that cancer could be prevented.

M. D. Anderson was among the first institutions to launch a broad, multifaceted cancer prevention program, and today - 10 years later - the Division of Cancer Prevention serves as a model for other prevention programs throughout the nation.

Levin's leadership of many collaborative research projects has resulted in identification of lifestyle factors, genetic predispositions and molecular events contributing to cancer development. As a gastrointestinal oncologist, Levin has contributed to unraveling the biochemical and genetic predeterminants of gastrointestinal cancers, as well as identification of new screening and treatment methods.

Cancer prevention researchers are advancing knowledge of disease processes, human behavior, clinical applications and community education, working to identify mechanisms of cancer prevention and then influencing individual behavior about appropriate choices to prevent disease. In addition, faculty train health care professionals, nationally and internationally, in delivery and application of prevention services.

Currently, M. D. Anderson prevention research includes:
  • Chemoprevention research for several disease sites, including lung, colon/rectum, cervix, bladder, prostate, breast, skin and esophagus

  • Human behavior related to tobacco, sun exposure, cancer screening practices, clinical trial participation and quality of life

  • Gene-environment interactions in cancer etiology, using advanced molecular and genetic techniques to explore changes at the level of a single cell - where the first changes toward cancer occur.

Levin's leadership positions include serving as co-chair of the National Cancer Institute's (NCI) Progress Review Group on Colorectal Cancer; chair, American Cancer Society's (ACS) National Colorectal Cancer Roundtable; co-chair, Digestive Health Initiative's Colorectal Cancer Campaign of the American Digestive Health Foundation; World Health Organization Collaborating Center on Colorectal Cancer; Medical Advisory Board, National Colorectal Cancer Research Alliance; chair, Detection and Treatment Advisory Group on Colorectal Cancer, ACS; and Advisory Board Member, Cancer Research Foundation of America.

Before assuming his role in cancer prevention, Levin served as chairman of M. D. Anderson's Department of Gastrointestinal Medical Oncology and Digestive Diseases. He earned his medical degree from the University of Witwatersrand Medical School in Johannesburg, South Africa, and completed his surgical and medical internships there. He moved to Chicago for an internal medicine residency and then completed fellowships in biochemistry/pathology and gastroenterology at the University of Chicago. He held academic appointments at the University of Chicago from 1971 until 1984, when he joined the faculty at M. D. Anderson to develop a multidisciplinary gastrointestinal cancer program.

University of Texas M. D. Anderson Cancer Center

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Moving Forward
When the life you've built slips out of your grasp, you're often told it's best to move on. But is that true? Instead of forgetting the past, TED speakers describe how we can move forward with it. Guests include writers Nora McInerny and Suleika Jaouad, and human rights advocate Lindy Lou Isonhood.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...